Protara Therapeutics, Inc. (TARA) Marketable Securities, Current USD 2021 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Protara Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2021 to 2024.
Protara Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $2.99 M, a 95.4% decline year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$2.99 M	-$62.6 M	-95.4%	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$26 M	-$34.2 M	-56.9%	Dec 31, 2023	10-Q	2024-05-02
Q3 2023	$40.3 M	-$8.55 M	-17.5%	Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$46.4 M	-$18.3 M	-28.2%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$65.6 M	+$3.42 M	+5.5%	Mar 31, 2023	10-Q	2023-05-04
Q4 2022	$60.2 M	+$4.74 M	+8.54%	Dec 31, 2022	10-K	2024-03-13
Q3 2022	$48.8 M	-$4.2 M	-7.92%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$64.6 M	+$26.8 M	+70.9%	Jun 30, 2022	10-Q	2022-08-09
Q1 2022	$62.2 M	+$36 M	+138%	Mar 31, 2022	10-Q	2022-05-05
Q4 2021	$55.5 M			Dec 31, 2021	10-K	2023-03-08
Q3 2021	$53 M			Sep 30, 2021	10-Q	2021-11-04
Q2 2021	$37.8 M			Jun 30, 2021	10-Q	2021-08-05
Q1 2021	$26.1 M			Mar 31, 2021	10-Q	2021-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.